NCT02425059View on ClinicalTrials.gov

Irreversible Electroporation(IRE) For Unresectable Rectal Neoplasms

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

December 1, 2020

Study Completion Date

February 1, 2021

Conditions
Rectal Neoplasms
Interventions
PROCEDURE

Irreversible electroporation (IRE)

Irreversible Electroportion For Unresectable Rectal Neoplasms guide with ultrasound or/and CT.

DEVICE

NanoKnife

Trial Locations (1)

510000

Biological treatment center in Fuda cancer hospital, Guangzhou

All Listed Sponsors
lead

Fuda Cancer Hospital, Guangzhou

OTHER

NCT02425059 - Irreversible Electroporation(IRE) For Unresectable Rectal Neoplasms | Biotech Hunter | Biotech Hunter